Skip to main content
Toggle navigation
Login
Search
Home
Full Schedule
Home
Full Schedule
All Days
Fri, Mar 31
Sat, Apr 1
Thu, Apr 20
Fri, Apr 21
Fri, May 19
Sat, May 20
Thu, Jun 15
Fri, Jun 16
Fri, Jul 21
Sat, Jul 22
Thu, Aug 17
Fri, Aug 18
Thu, Sep 14
Fri, Sep 15
Full Schedule
Type here to filter the list
Friday, June 16, 2023
8:00 AM - 8:45 AM
.
Session IV: Special Situations in UC
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his)
– University of Maryland School of Medicine
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
8:00 AM - 8:45 AM
.
Session IV: Special Situations in UC
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his)
– University of Maryland School of Medicine
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
8:00 AM - 8:15 AM
.
Management of the Hospitalized UC Patient
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his)
– University of Maryland School of Medicine
8:15 AM - 8:30 AM
.
Dysplasia in IBD: Best Practices
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
8:00 AM - 8:45 AM
.
Session VI: Special Situations in UC
8:30 AM - 8:45 AM
.
Q&A Panel
9:00 AM - 10:00 AM
.
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
Speaker:
Florian Rieder, MD
– Cleveland Clinic
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
9:00 AM - 10:00 AM
.
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
Speaker:
Florian Rieder, MD
– Cleveland Clinic
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
9:00 AM - 9:15 AM
.
Small But Mighty: JAK Inhibitors
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
9:15 AM - 9:30 AM
.
'Old' But True: Anti-TNF and Anti-Integrins
Speaker:
Florian Rieder, MD
– Cleveland Clinic
9:30 AM - 9:45 AM
.
The 'New' Wave: Anti-Interleukins Are Here
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
9:45 AM - 10:00 AM
.
Q&A Panel
10:15 AM - 11:15 AM
.
Non-CME Innovation Theater: A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients
10:15 AM - 11:15 AM
.
Non-CME Innovation Theater: A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients
11:30 AM - 12:15 PM
.
Session VI: Optimizing Existing Therapies in the Management of IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
11:30 AM - 12:15 PM
.
Session VI: Optimizing Existing Therapies in the Management of IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
11:30 AM - 12:00 PM
.
Optimizing Existing Therapies in the Management of IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
12:00 PM - 12:15 PM
.
Q&A Panel
12:30 PM - 1:15 PM
.
Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his)
– University of Maryland School of Medicine
12:30 PM - 1:15 PM
.
Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his)
– University of Maryland School of Medicine
12:30 PM - 1:00 PM
.
Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
1:00 PM - 1:15 PM
.
Q&A Panel
1:30 PM - 2:30 PM
.
Non-CME Innovation Theater: UC Results: a peer-to-peer review of clinical outcomes and long-term safety of a JAK inhibitor for patients with UC
1:30 PM - 2:30 PM
.
Non-CME Innovation Theater: UC Results: a peer-to-peer review of clinical outcomes and long-term safety of a JAK inhibitor for patients with UC
2:45 PM - 3:30 PM
.
Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
2:45 PM - 3:30 PM
.
Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
2:45 PM - 3:15 PM
.
Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:15 PM - 3:30 PM
.
Q&A Panel
3:45 PM - 4:30 PM
.
Session IX: Putting your knowledge to the test: Challenging IBD cases
Panelist:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his)
– University of Maryland School of Medicine
Panelist:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:45 PM - 4:30 PM
.
Session IX: Putting your knowledge to the test: Challenging IBD cases
Panelist:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his)
– University of Maryland School of Medicine
Panelist:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:45 PM - 4:30 PM
.
Putting your knowledge to the test: Challenging IBD cases
Moderator:
Stephen B. Hanauer, MD, MACG
– Northwestern University Feinberg School of Medicine
Panelist:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG (he/him/his)
– University of Maryland School of Medicine
Panelist:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
